Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2022-05-06 00:00:00 ET · period of report 2022-05-05 · accession 0001179110-22-002906 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-06 | 2022-05-05 | HALO | BIZZARI JEAN-PIERRE | Dir | A - Grant | $0.00 | +6,206 | 58.8K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock Units | 2022-05-05 | A | A | 6,206 | $0.00 | 58,750 | D | — | — | (F1) Represents annual restricted stock unit grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2023 and (ii) the date of the Issuer's next annual meeting of stockholders. |